Insider Trading disclosures for Intra-Cellular Therapies Inc

The latest disclosure was made by Michael I. Halstead in Intra-Cellular Therapies Inc where a trade of 7,345 Common Stock done was reported to US exchanges on March 6, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Michael I. Halstead	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2025	7,345	25,064 (0%)	0%		-	Common Stock
Michael I. Halstead	President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.24 per share.	06 Mar 2025	3,757	21,307 (0%)	0%	131.2	493,069	Common Stock
Michael I. Halstead	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2025	13,133	13,133	-		-	Restricted Stock Units
Michael I. Halstead	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2025	7,345	0	-		-	Restricted Stock Units
Michael I. Halstead	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2025	13,133	24,437 (0%)	0%		-	Common Stock
Michael I. Halstead	President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.19 per share.	06 Mar 2025	6,718	17,719 (0%)	0%	131.2	881,334	Common Stock
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2025	40,712	1,144,646 (1%)	0%		-	Common Stock
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2025	20,566	0	-		-	Restricted Stock Units
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2025	40,712	40,713	-		-	Restricted Stock Units
Sharon Mates	Director, Chairman and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.24 per share.	06 Mar 2025	10,129	1,135,235 (1%)	0%	131.2	1,329,330	Common Stock
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2025	20,566	1,145,364 (1%)	0%		-	Common Stock
Sharon Mates	Director, Chairman and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.19 per share.	06 Mar 2025	19,848	1,124,798 (1%)	0%	131.2	2,603,859	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2025	13,133	54,154 (0%)	0%		-	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2025	7,345	0	-		-	Restricted Stock Units
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2025	13,133	13,133	-		-	Restricted Stock Units
Mark Neumann	EVP, Chief Commercial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.24 per share.	06 Mar 2025	3,116	52,811 (0%)	0%	131.2	408,944	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2025	7,345	55,927 (0%)	0%		-	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.19 per share.	06 Mar 2025	5,572	48,582 (0%)	0%	131.2	730,991	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2025	7,345	0	-		-	Restricted Stock Units
Suresh K. Durgam	EVP, Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.19 per share.	06 Mar 2025	5,572	38,684 (0%)	0%	131.2	730,991	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2025	7,345	46,029 (0%)	0%		-	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2025	13,133	44,256 (0%)	0%		-	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.24 per share.	06 Mar 2025	3,116	42,913 (0%)	0%	131.2	408,944	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2025	13,133	13,133	-		-	Restricted Stock Units
Michael I. Halstead	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2025	12,239	17,565 (0%)	0%		-	Common Stock
Michael I. Halstead	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2025	12,239	24,478	-		-	Restricted Stock Units
Michael I. Halstead	President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.20 per share.	01 Mar 2025	6,261	11,304 (0%)	0%	128.2	802,660	Common Stock
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2025	34,969	69,940	-		-	Restricted Stock Units
Sharon Mates	Director, Chairman and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.20 per share.	01 Mar 2025	16,978	1,103,934 (1%)	0%	128.2	2,176,580	Common Stock
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2025	34,969	1,120,912 (1%)	0%		-	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2025	8,742	44,730 (0%)	0%		-	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2025	8,742	17,485	-		-	Restricted Stock Units
Mark Neumann	EVP, Chief Commercial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.20 per share.	01 Mar 2025	3,709	41,021 (0%)	0%	128.2	475,494	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.20 per share.	01 Mar 2025	3,709	31,123 (0%)	0%	128.2	475,494	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2025	8,742	17,485	-		-	Restricted Stock Units
Suresh K. Durgam	EVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2025	8,742	34,832 (0%)	0%		-	Common Stock
Joel S. Marcus	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.79 per share.	24 Feb 2025	7,009	48,238 (0%)	0%	63.8	447,104	Common Stock
Joel S. Marcus	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Feb 2025	7,009	0	-		-	Stock Option (right to buy)
Sanjeev Narula	Executive Vice President & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2025	22,727	22,727	-		-	Restricted Stock Units
Michael I. Halstead	President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	11,017	11,017 (0%)	0%		0	Common Stock
Michael I. Halstead	President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.00 per share.	31 Jan 2025	5,691	5,326 (0%)	0%	127	722,757	Common Stock
Michael I. Halstead	President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	45,454	45,454	-		-	Restricted Stock Units
Sharon Mates	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	121,212	121,212	-		-	Restricted Stock Units
Sharon Mates	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	30,847	1,101,176 (1%)	0%		0	Common Stock
Sharon Mates	Director, Chairman and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.00 per share.	31 Jan 2025	15,233	1,085,943 (1%)	0%	127	1,934,591	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	11,017	40,717 (0%)	0%		0	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.00 per share.	31 Jan 2025	4,729	35,988 (0%)	0%	127	600,583	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	22,727	22,727	-		-	Restricted Stock Units
Suresh K. Durgam	EVP, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	11,017	30,820 (0%)	0%		0	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.00 per share.	31 Jan 2025	4,730	26,090 (0%)	0%	127	600,710	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	24,621	24,621	-		-	Restricted Stock Units
Rory B. Riggs	Director	Grant, award, or other acquisition of securities at price $ 83.52 per share.	31 Dec 2024	215	131,512 (0%)	0%	83.5	17,957	Common Stock
Mates Sharon	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.73 per share.	04 Dec 2024	51,697	1,122,026 (1%)	0%	12.7	658,103	Common Stock
Sharon Mates	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 84.69 per share.	04 Dec 2024	1,534	1,070,329 (1%)	0%	84.7	129,914	Common Stock
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Dec 2024	51,000	51,697	-		-	Stock Option (right to buy)
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.73 per share.	04 Dec 2024	51,000	1,121,329 (1%)	0%	12.7	649,230	Common Stock
Mates Sharon	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 86.00 per share.	04 Dec 2024	23,333	1,070,329 (1%)	0%	86.0	2,006,750	Common Stock
Mates Sharon	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 85.62 per share.	04 Dec 2024	27,667	1,093,662 (1%)	0%	85.6	2,368,909	Common Stock
Mates Sharon	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Dec 2024	51,697	0	-		-	Stock Option (right to buy)
Sharon Mates	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 84.06 per share.	04 Dec 2024	50,163	1,071,863 (1%)	0%	84.1	4,216,928	Common Stock
Michael I. Halstead	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.94 per share.	12 Nov 2024	22,869	22,869 (0%)	0%	23.9	547,484	Common Stock
Michael I. Halstead	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Nov 2024	22,869	0	-		-	Stock Option (right to buy)
Michael I. Halstead	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Nov 2024	18,714	0	-		-	Stock Option (right to buy)
Michael I. Halstead	President	Sale of securities on an exchange or to another person at price $ 88.92 per share.	12 Nov 2024	5,343	0 (0%)	0%	88.9	475,100	Common Stock
Michael I. Halstead	President	Sale of securities on an exchange or to another person at price $ 88.17 per share.	12 Nov 2024	13,371	5,343 (0%)	0%	88.2	1,178,921	Common Stock
Michael I. Halstead	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.89 per share.	12 Nov 2024	18,714	18,714 (0%)	0%	36.9	690,359	Common Stock
Michael I. Halstead	President	Sale of securities on an exchange or to another person at price $ 90.89 per share.	12 Nov 2024	1,648	0 (0%)	0%	90.9	149,787	Common Stock
Michael I. Halstead	President	Sale of securities on an exchange or to another person at price $ 89.63 per share.	12 Nov 2024	6,116	1,648 (0%)	0%	89.6	548,177	Common Stock
Michael I. Halstead	President	Sale of securities on an exchange or to another person at price $ 88.72 per share.	12 Nov 2024	15,105	7,764 (0%)	0%	88.7	1,340,116	Common Stock
Rory B. Riggs	Director	Grant, award, or other acquisition of securities at price $ 73.17 per share.	30 Sep 2024	246	117,108 (0%)	0%	73.2	18,000	Common Stock
Sharon Mates	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 73.32 per share.	29 Aug 2024	6,193	1,070,329 (1%)	0%	73.3	454,091	Common Stock
Sharon Mates	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 72.73 per share.	29 Aug 2024	28,203	1,076,522 (1%)	0%	72.7	2,051,261	Common Stock
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.73 per share.	29 Aug 2024	34,396	1,104,725 (1%)	0%	12.7	437,861	Common Stock
Sharon Mates	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 73.25 per share.	29 Aug 2024	5,772	1,070,329 (1%)	0%	73.2	422,771	Common Stock
Sharon Mates	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 72.44 per share.	29 Aug 2024	29,832	1,076,101 (1%)	0%	72.4	2,161,114	Common Stock
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.73 per share.	29 Aug 2024	35,604	1,105,933 (1%)	0%	12.7	453,239	Common Stock
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Aug 2024	34,396	102,697	-		-	Stock Option (right to buy)
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Aug 2024	35,604	137,093	-		-	Stock Option (right to buy)
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Aug 2024	40,513	32,699	-		-	Stock Option (right to buy)
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Aug 2024	22,713	73,212	-		-	Stock Option (right to buy)
Sharon Mates	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 73.70 per share.	26 Aug 2024	240	1,070,329 (1%)	0%	73.7	17,688	Common Stock
Sharon Mates	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 72.74 per share.	26 Aug 2024	32,459	1,070,569 (1%)	0%	72.7	2,361,113	Common Stock
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.57 per share.	26 Aug 2024	32,699	1,103,028 (1%)	0%	17.6	574,521	Common Stock
Sharon Mates	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 73.93 per share.	26 Aug 2024	16,856	1,070,329 (1%)	0%	73.9	1,246,191	Common Stock
Sharon Mates	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 73.33 per share.	26 Aug 2024	23,657	1,087,185 (1%)	0%	73.3	1,734,865	Common Stock
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.57 per share.	26 Aug 2024	40,513	1,110,842 (1%)	0%	17.6	711,813	Common Stock
Sharon Mates	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 74.59 per share.	26 Aug 2024	22,713	1,070,329 (1%)	0%	74.6	1,694,229	Common Stock
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.57 per share.	26 Aug 2024	22,713	1,093,042 (1%)	0%	17.6	399,067	Common Stock
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Aug 2024	32,699	0	-		-	Stock Option (right to buy)
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.57 per share.	21 Aug 2024	53,013	1,123,342 (1%)	0%	17.6	931,438	Common Stock
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Aug 2024	28,680	95,925	-		-	Stock Option (right to buy)
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Aug 2024	39,380	124,605	-		-	Stock Option (right to buy)
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Aug 2024	53,013	163,985	-		-	Stock Option (right to buy)
Sharon Mates	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 74.46 per share.	21 Aug 2024	28,680	1,070,329 (1%)	0%	74.5	2,135,435	Common Stock
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.57 per share.	21 Aug 2024	28,680	1,099,009 (1%)	0%	17.6	503,908	Common Stock
Sharon Mates	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 75.47 per share.	21 Aug 2024	4,369	1,070,329 (1%)	0%	75.5	329,727	Common Stock
Sharon Mates	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 74.58 per share.	21 Aug 2024	35,011	1,074,698 (1%)	0%	74.6	2,611,075	Common Stock
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.57 per share.	21 Aug 2024	39,380	1,109,709 (1%)	0%	17.6	691,907	Common Stock
Sharon Mates	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 77.98 per share.	21 Aug 2024	1,900	1,070,329 (1%)	0%	78.0	148,163	Common Stock
Sharon Mates	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 77.21 per share.	21 Aug 2024	2,682	1,072,229 (1%)	0%	77.2	207,088	Common Stock
Sharon Mates	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 76.20 per share.	21 Aug 2024	4,297	1,074,911 (1%)	0%	76.2	327,432	Common Stock
Sharon Mates	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 75.40 per share.	21 Aug 2024	44,134	1,079,208 (1%)	0%	75.4	3,327,818	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.89 per share.	16 Aug 2024	18,714	48,414 (0%)	0%	36.9	690,359	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Aug 2024	18,714	0	-		-	Stock Option (right to buy)
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 75.08 per share.	16 Aug 2024	18,714	29,700 (0%)	0%	75.1	1,405,047	Common Stock
Sanjeev Narula	Executive Vice President & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Aug 2024	17,251	17,251	-		-	Stock Option (right to buy)
Sanjeev Narula	Executive Vice President & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Aug 2024	35,046	35,046	-		-	Restricted Stock Units
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 68.49 per share.	28 Jun 2024	83	11,340 (0%)	0%	68.5	5,685	Common Stock
Rory B. Riggs	Director	Grant, award, or other acquisition of securities at price $ 68.49 per share.	28 Jun 2024	262	116,862 (0%)	0%	68.5	17,944	Common Stock
Joel S. Marcus	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2024	1,567	41,229 (0%)	0%		-	Common Stock
Joel S. Marcus	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2024	1,567	0	-		-	Restricted Stock Units
Robert L. Van Nostrand	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2024	1,567	0	-		-	Restricted Stock Units
Robert L. Van Nostrand	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2024	1,567	11,257 (0%)	0%		-	Common Stock
Rory B. Riggs	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2024	20,000	0	-		-	Stock Option (right to buy)
Rory B. Riggs	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2024	1,567	0	-		-	Restricted Stock Units
Rory B. Riggs	Director	Sale of securities on an exchange or to another person at price $ 75.57 per share.	23 Jun 2024	4,462	116,600 (0%)	0%	75.6	337,193	Common Stock
Rory B. Riggs	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.86 per share.	23 Jun 2024	20,000	121,062 (0%)	0%	16.9	337,200	Common Stock
Rory B. Riggs	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2024	1,567	101,062 (0%)	0%		-	Common Stock
Eduardo Rene Salas	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2024	1,567	0	-		-	Restricted Stock Units
Eduardo Rene Salas	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2024	1,567	1,567 (0%)	0%		-	Common Stock
Robert L. Van Nostrand	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.86 per share.	18 Jun 2024	20,000	29,690 (0%)	0%	16.9	337,200	Common Stock
Robert L. Van Nostrand	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Jun 2024	20,000	0	-		-	Stock Option (right to buy)
Robert L. Van Nostrand	Director	Sale of securities on an exchange or to another person at price $ 76.07 per share.	18 Jun 2024	11,109	9,690 (0%)	0%	76.1	845,062	Common Stock
Robert L. Van Nostrand	Director	Sale of securities on an exchange or to another person at price $ 75.71 per share.	18 Jun 2024	8,891	20,799 (0%)	0%	75.7	673,138	Common Stock
Joel S. Marcus	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2024	2,951	2,951	-		-	Restricted Stock Units
Joel S. Marcus	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2024	4,322	4,322	-		-	Stock Option (right to buy)
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2024	4,322	4,322	-		-	Stock Option (right to buy)
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2024	2,951	2,951	-		-	Restricted Stock Units
Rory B. Riggs	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2024	4,322	4,322	-		-	Stock Option (right to buy)
Rory B. Riggs	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2024	2,951	2,951	-		-	Restricted Stock Units
Eduardo Rene Salas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2024	2,951	2,951	-		-	Restricted Stock Units
Eduardo Rene Salas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2024	4,322	4,322	-		-	Stock Option (right to buy)
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Apr 2024	11,382	216,998	-		-	Stock Option (right to buy)
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.86 per share.	24 Apr 2024	8,638	1,058,947 (1%)	0%	16.9	145,637	Common Stock
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.57 per share.	24 Apr 2024	11,382	1,070,329 (1%)	0%	17.6	199,982	Common Stock
Sharon Mates	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Apr 2024	8,638	0	-		-	Stock Option (right to buy)
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 69.20 per share.	31 Mar 2024	79	9,690 (0%)	0%	69.2	5,467	Common Stock
Rory B. Riggs	Director	Grant, award, or other acquisition of securities at price $ 69.20 per share.	31 Mar 2024	260	99,495 (0%)	0%	69.2	17,992	Common Stock
Rory B. Riggs	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Mar 2024	20,000	0	-		-	Stock Option (right to buy)
Rory B. Riggs	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.56 per share.	20 Mar 2024	20,000	99,235 (0%)	0%	18.6	371,200	Common Stock
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Mar 2024	7,345	7,345	-		-	Restricted Stock Units
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 66.70 per share.	07 Mar 2024	1,238	0 (0%)	0%	66.7	82,575	Common Stock
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Mar 2024	7,345	7,345 (0%)	0%		-	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 66.14 per share.	07 Mar 2024	12,912	220 (0%)	0%	66.1	854,000	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 65.82 per share.	07 Mar 2024	6,107	1,238 (0%)	0%	65.8	401,963	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 66.81 per share.	07 Mar 2024	220	0 (0%)	0%	66.8	14,698	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 64.80 per share.	07 Mar 2024	14,541	1,056,333 (1%)	0%	64.8	942,257	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 66.93 per share.	07 Mar 2024	8,754	1,050,309 (1%)	0%	66.9	585,905	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Mar 2024	20,565	1,070,874 (1%)	0%		-	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 66.38 per share.	07 Mar 2024	31,958	1,059,063 (1%)	0%	66.4	2,121,372	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Mar 2024	20,565	20,566	-		-	Restricted Stock Units
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 67.33 per share.	07 Mar 2024	306	1,050,309 (1%)	0%	67.3	20,603	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 66.81 per share.	07 Mar 2024	1,590	1,050,615 (1%)	0%	66.8	106,228	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 65.90 per share.	07 Mar 2024	4,128	1,052,205 (1%)	0%	65.9	272,035	Common Stock
Lawrence J. Hineline	SVP of Finance, CFO	Sale of securities on an exchange or to another person at price $ 66.93 per share.	07 Mar 2024	6,618	0 (0%)	0%	66.9	442,943	Common Stock
Lawrence J. Hineline	SVP of Finance, CFO	Sale of securities on an exchange or to another person at price $ 66.26 per share.	07 Mar 2024	6,514	6,618 (0%)	0%	66.3	431,618	Common Stock
Lawrence J. Hineline	SVP of Finance, CFO	Sale of securities on an exchange or to another person at price $ 67.12 per share.	07 Mar 2024	64	0 (0%)	0%	67.1	4,296	Common Stock
Lawrence J. Hineline	SVP of Finance, CFO	Sale of securities on an exchange or to another person at price $ 66.47 per share.	07 Mar 2024	4,475	64 (0%)	0%	66.5	297,453	Common Stock
Lawrence J. Hineline	SVP of Finance, CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.73 per share.	07 Mar 2024	4,539	4,539 (0%)	0%	56.7	257,497	Common Stock
Lawrence J. Hineline	SVP of Finance, CFO	Sale of securities on an exchange or to another person at price $ 67.31 per share.	07 Mar 2024	29	0 (0%)	0%	67.3	1,952	Common Stock
Lawrence J. Hineline	SVP of Finance, CFO	Sale of securities on an exchange or to another person at price $ 66.54 per share.	07 Mar 2024	1,100	29 (0%)	0%	66.5	73,194	Common Stock
Lawrence J. Hineline	SVP of Finance, CFO	Sale of securities on an exchange or to another person at price $ 65.28 per share.	07 Mar 2024	4,453	1,129 (0%)	0%	65.3	290,692	Common Stock
Lawrence J. Hineline	SVP of Finance, CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Mar 2024	5,582	5,582 (0%)	0%		-	Common Stock
Lawrence J. Hineline	SVP of Finance, CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Mar 2024	4,539	4,539	-		-	Stock Option (right to purchase)
Lawrence J. Hineline	SVP of Finance, CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Mar 2024	5,582	5,582	-		-	Restricted Stock Units
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Mar 2024	7,345	7,345	-		-	Restricted Stock Units
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 66.86 per share.	07 Mar 2024	1,313	29,700 (0%)	0%	66.9	87,787	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 65.92 per share.	07 Mar 2024	1,729	31,013 (0%)	0%	65.9	113,976	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 65.11 per share.	07 Mar 2024	4,303	32,742 (0%)	0%	65.1	280,168	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Mar 2024	7,345	37,045 (0%)	0%		-	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 66.95 per share.	07 Mar 2024	4,496	29,700 (0%)	0%	66.9	301,007	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 66.37 per share.	07 Mar 2024	8,636	34,196 (0%)	0%	66.4	573,171	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 66.96 per share.	07 Mar 2024	661	19,803 (0%)	0%	67.0	44,261	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 65.06 per share.	07 Mar 2024	2,179	21,336 (0%)	0%	65.1	141,766	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 66.34 per share.	07 Mar 2024	3,728	18,892 (0%)	0%	66.3	247,316	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 66.86 per share.	07 Mar 2024	2,722	16,170 (0%)	0%	66.9	181,993	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Mar 2024	7,345	23,515 (0%)	0%		-	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Mar 2024	7,345	7,345	-		-	Restricted Stock Units
Suresh K. Durgam	EVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 65.89 per share.	07 Mar 2024	872	20,464 (0%)	0%	65.9	57,456	Common Stock
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2024	13,132	26,266	-		-	Restricted Stock Units
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2024	13,132	13,132 (0%)	0%		-	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2024	40,712	81,425	-		-	Restricted Stock Units
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2024	40,712	1,091,021 (1%)	0%		-	Common Stock
Lawrence J. Hineline	SVP of Finance, CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2024	13,132	26,266	-		-	Restricted Stock Units
Lawrence J. Hineline	SVP of Finance, CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2024	13,132	13,132 (0%)	0%		-	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2024	13,132	26,266	-		-	Restricted Stock Units
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2024	13,132	42,832 (0%)	0%		-	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2024	13,132	26,266	-		-	Restricted Stock Units
Suresh K. Durgam	EVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2024	13,132	22,620 (0%)	0%		-	Common Stock
Michael I. Halstead	EVP and General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2024	36,717	36,717	-		-	Restricted Stock Units
Sharon Mates	Director, Chairman, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2024	104,909	104,909	-		-	Restricted Stock Units
Lawrence J. Hineline	SVP of Finance, CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2024	26,227	26,227	-		-	Restricted Stock Units
Mark Neumann	EVP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2024	26,227	26,227	-		-	Restricted Stock Units
Suresh K. Durgam	EVP, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2024	26,227	26,227	-		-	Restricted Stock Units
Van Nostrand L. Robert	Director	Sale of securities on an exchange or to another person at price $ 73.14 per share.	27 Feb 2024	10,349	9,611 (0%)	0%	73.1	756,926	Common Stock
L. Robert Van Nostrand	Director	Sale of securities on an exchange or to another person at price $ 72.71 per share.	27 Feb 2024	9,651	19,960 (0%)	0%	72.7	701,724	Common Stock
L. Robert Van Nostrand	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.56 per share.	27 Feb 2024	20,000	29,611 (0%)	0%	18.6	371,200	Common Stock
Robert L. Van Nostrand	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2024	20,000	0	-		-	Stock Option (right to buy)
S. Joel Marcus	Director	Sale of securities on an exchange or to another person at price $ 67.83 per share.	26 Feb 2024	8,371	57,619 (0%)	0%	67.8	567,805	Common Stock
Joel Marcus S.	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.45 per share.	26 Feb 2024	20,000	49,233 (0%)	0%	43.5	869,000	Common Stock
Marcus Joel S.	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2024	20,000	0	-		-	Stock Option (right to buy)
Joel S. Marcus	Director	Sale of securities on an exchange or to another person at price $ 69.60 per share.	26 Feb 2024	299	39,662 (0%)	0%	69.6	20,810	Common Stock
S. Joel Marcus	Director	Sale of securities on an exchange or to another person at price $ 69.07 per share.	26 Feb 2024	17,658	39,961 (0%)	0%	69.1	1,219,638	Common Stock
S. Marcus Joel	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.48 per share.	26 Feb 2024	16,757	65,990 (0%)	0%	55.5	929,678	Common Stock
Marcus S. Joel	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2024	16,757	0	-		-	Stock Option (right to buy)
Mates Sharon	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 69.45 per share.	23 Feb 2024	9,528	1,062,771 (1%)	0%	69.5	661,720	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 70.11 per share.	23 Feb 2024	12,462	1,050,309 (1%)	0%	70.1	873,711	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 71.18 per share.	23 Feb 2024	1,307	29,700 (0%)	0%	71.2	93,032	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2024	7,907	0	-		-	Restricted Stock Units
J. Lawrence Hineline	SVP of Finance, CFO	Sale of securities on an exchange or to another person at price $ 69.47 per share.	23 Feb 2024	5,282	600 (0%)	0%	69.5	366,941	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 70.16 per share.	23 Feb 2024	1,400	10,800 (0%)	0%	70.2	98,224	Common Stock
Michael Halstead I.	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2024	7,907	7,907 (0%)	0%		-	Common Stock
K. Durgam Suresh	EVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 71.02 per share.	23 Feb 2024	1,312	9,488 (0%)	0%	71.0	93,178	Common Stock
Neumann Mark	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 70.70 per share.	23 Feb 2024	2,341	31,007 (0%)	0%	70.7	165,509	Common Stock
Lawrence J. Hineline	SVP of Finance, CFO	Sale of securities on an exchange or to another person at price $ 68.33 per share.	23 Feb 2024	300	7,155 (0%)	0%	68.3	20,499	Common Stock
J. Lawrence Hineline	SVP of Finance, CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2024	7,455	0	-		-	Restricted Stock Units
Lawrence J. Hineline	SVP of Finance, CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2024	5,882	0	-		-	Stock Option (right to buy)
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 68.54 per share.	23 Feb 2024	300	7,607 (0%)	0%	68.5	20,562	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 70.13 per share.	23 Feb 2024	392	0 (0%)	0%	70.1	27,491	Common Stock
Hineline J. Lawrence	SVP of Finance, CFO	Sale of securities on an exchange or to another person at price $ 69.81 per share.	23 Feb 2024	600	0 (0%)	0%	69.8	41,886	Common Stock
Michael Halstead I.	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2024	7,907	0	-		-	Restricted Stock Units
I. Halstead Michael	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 69.54 per share.	23 Feb 2024	7,215	392 (0%)	0%	69.5	501,731	Common Stock
Mates Sharon	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2024	22,590	1,072,899 (1%)	0%		-	Common Stock
Neumann Mark	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 69.56 per share.	23 Feb 2024	4,059	33,348 (0%)	0%	69.6	282,344	Common Stock
Mates Sharon	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 68.39 per share.	23 Feb 2024	600	1,072,299 (1%)	0%	68.4	41,034	Common Stock
Mates Sharon	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2024	22,590	0	-		-	Restricted Stock Units
K. Durgam Suresh	EVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2024	7,907	13,600 (0%)	0%		-	Common Stock
Neumann Mark	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2024	7,907	37,607 (0%)	0%		-	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 68.03 per share.	23 Feb 2024	200	37,407 (0%)	0%	68.0	13,606	Common Stock
Durgam K. Suresh	EVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2024	7,907	0	-		-	Restricted Stock Units
J. Hineline Lawrence	SVP of Finance, CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.89 per share.	23 Feb 2024	5,882	5,882 (0%)	0%	36.9	216,987	Common Stock
K. Suresh Durgam	EVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 69.38 per share.	23 Feb 2024	1,400	12,200 (0%)	0%	69.4	97,132	Common Stock
Hineline J. Lawrence	SVP of Finance, CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2024	7,455	7,455 (0%)	0%		-	Common Stock
Lawrence Hineline J.	SVP of Finance, CFO	Sale of securities on an exchange or to another person at price $ 69.38 per share.	23 Feb 2024	6,867	288 (0%)	0%	69.4	476,432	Common Stock
J. Lawrence Hineline	SVP of Finance, CFO	Sale of securities on an exchange or to another person at price $ 70.15 per share.	23 Feb 2024	288	0 (0%)	0%	70.1	20,203	Common Stock
Neumann Mark	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 67.49 per share.	01 Feb 2024	6,904	29,700 (0%)	0%	67.5	465,951	Common Stock
Suresh Durgam K.	EVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 66.69 per share.	01 Feb 2024	2,320	9,540 (0%)	0%	66.7	154,721	Common Stock
Suresh Durgam K.	EVP, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2024	11,860	11,860 (0%)	0%		0	Common Stock
I. Halstead Michael	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 66.37 per share.	01 Feb 2024	11,146	714 (0%)	0%	66.4	739,760	Common Stock
Lawrence J. Hineline	SVP of Finance, CFO	Sale of securities on an exchange or to another person at price $ 66.61 per share.	01 Feb 2024	10,998	185 (0%)	0%	66.6	732,577	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2024	33,885	1,084,194 (1%)	0%		0	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 67.49 per share.	01 Feb 2024	3,847	5,693 (0%)	0%	67.5	259,634	Common Stock
J. Hineline Lawrence	SVP of Finance, CFO	Sale of securities on an exchange or to another person at price $ 67.35 per share.	01 Feb 2024	185	0 (0%)	0%	67.4	12,460	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 67.17 per share.	01 Feb 2024	714	0 (0%)	0%	67.2	47,959	Common Stock
I. Michael Halstead	EVP and General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2024	11,860	11,860 (0%)	0%		0	Common Stock
Lawrence Hineline J.	SVP of Finance, CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2024	11,183	11,183 (0%)	0%		0	Common Stock
Neumann Mark	EVP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2024	11,860	41,560 (0%)	0%		0	Common Stock
Mates Sharon	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 67.42 per share.	01 Feb 2024	17,450	1,050,309 (1%)	0%	67.4	1,176,479	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 66.67 per share.	01 Feb 2024	4,956	36,604 (0%)	0%	66.7	330,417	Common Stock
Mates Sharon	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 66.70 per share.	01 Feb 2024	16,435	1,067,759 (1%)	0%	66.7	1,096,215	Common Stock
Mates Sharon	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 65.19 per share.	16 Jan 2024	67,597	1,050,629 (1%)	0%	65.2	4,406,648	Common Stock
Mates Sharon	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.86 per share.	16 Jan 2024	48,084	1,098,393 (1%)	0%	16.9	810,696	Common Stock
Mates Sharon	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 66.66 per share.	16 Jan 2024	17,451	1,050,309 (1%)	0%	66.7	1,163,284	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 67.76 per share.	16 Jan 2024	5,882	1,050,309 (1%)	0%	67.8	398,564	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 66.00 per share.	16 Jan 2024	30,633	1,067,760 (1%)	0%	66	2,021,778	Common Stock
Mates Sharon	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 66.38 per share.	16 Jan 2024	3,500	1,122,170 (1%)	0%	66.4	232,330	Common Stock
Mates Sharon	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Jan 2024	48,084	76,555	-		-	Stock Option (right to buy)
Mates Sharon	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Jan 2024	67,917	8,638	-		-	Stock Option (right to buy)
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 66.25 per share.	16 Jan 2024	320	1,050,309 (1%)	0%	66.3	21,200	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Jan 2024	75,361	124,639	-		-	Stock Option (right to buy)
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.86 per share.	16 Jan 2024	67,917	1,118,226 (1%)	0%	16.9	1,145,081	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 67.25 per share.	16 Jan 2024	65,979	1,056,191 (1%)	0%	67.3	4,437,088	Common Stock
Mates Sharon	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.86 per share.	16 Jan 2024	75,361	1,125,670 (1%)	0%	16.9	1,270,586	Common Stock
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.73 per share.	11 Jan 2024	46,115	46,115 (0%)	0%	12.7	587,044	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 67.80 per share.	11 Jan 2024	1,486	0 (0%)	0%	67.8	100,751	Common Stock
Michael Halstead I.	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Jan 2024	46,115	0	-		-	Stock Option (right to buy)
Michael Halstead I.	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 66.31 per share.	11 Jan 2024	18,154	31,846 (0%)	0%	66.3	1,203,792	Common Stock
Michael Halstead I.	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Jan 2024	3,885	22,869	-		-	Stock Option (right to buy)
I. Halstead Michael	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 67.10 per share.	11 Jan 2024	30,360	1,486 (0%)	0%	67.1	2,037,156	Common Stock
Halstead I. Michael	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.94 per share.	11 Jan 2024	3,885	50,000 (0%)	0%	23.9	93,007	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 70.80 per share.	02 Jan 2024	22,645	2,210 (0%)	0%	70.8	1,603,266	Common Stock
Durgam Suresh K.	EVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	62,282	0	-		-	Stock Option (right to buy)
Durgam Suresh K.	EVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.87 per share.	02 Jan 2024	62,282	62,282 (0%)	0%	19.9	1,237,543	Common Stock
K. Durgam Suresh	EVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 71.77 per share.	02 Jan 2024	2,210	0 (0%)	0%	71.8	158,612	Common Stock
K. Suresh Durgam	EVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 70.41 per share.	02 Jan 2024	37,427	24,855 (0%)	0%	70.4	2,635,235	Common Stock
Van Nostrand L. Robert	Director	Grant, award, or other acquisition of securities at price $ 71.62 per share.	31 Dec 2023	76	9,611 (0%)	0%	71.6	5,443	Common Stock
B. Riggs Rory	Director	Grant, award, or other acquisition of securities at price $ 71.62 per share.	31 Dec 2023	251	79,235 (0%)	0%	71.6	17,977	Common Stock
Durgam Suresh K.	EVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 65.00 per share.	13 Dec 2023	21,262	0 (0%)	0%	65	1,382,030	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Aug 2023	55,300	0	-		-	Stock Option (right to buy)
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 58.79 per share.	07 Aug 2023	55,300	45,339 (0%)	0%	58.8	3,251,087	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.59 per share.	07 Aug 2023	55,300	100,639 (0%)	0%	18.6	1,028,027	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 65.00 per share.	17 Jul 2023	1,842	21,262 (0%)	0%	65	119,730	Common Stock
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 63.32 per share.	30 Jun 2023	85	9,430 (0%)	0%	63.3	5,382	Common Stock
Rory B. Riggs	Director	Grant, award, or other acquisition of securities at price $ 63.32 per share.	30 Jun 2023	279	78,639 (0%)	0%	63.3	17,666	Common Stock
Joel S. Marcus	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2023	7,009	7,009	-		-	Stock Option (right to buy)
Joel S. Marcus	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2023	1,567	1,567	-		-	Restricted Stock Units
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2023	1,567	1,567	-		-	Restricted Stock Units
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2023	7,009	7,009	-		-	Stock Option (right to buy)
Rory B. Riggs	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2023	7,009	7,009	-		-	Stock Option (right to buy)
Rory B. Riggs	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2023	1,567	1,567	-		-	Restricted Stock Units
Eduardo Rene Salas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2023	1,567	1,567	-		-	Restricted Stock Units
Eduardo Rene Salas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2023	7,009	7,009	-		-	Stock Option (right to buy)
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Jun 2023	11,762	5,882	-		-	Stock Option (right to purchase)
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Jun 2023	4,538	9,078	-		-	Stock Option (right to purchase)
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Jun 2023	25,082	0	-		-	Stock Option (right to purchase)
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Jun 2023	40,472	0	-		-	Stock Option (right to purchase)
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 65.01 per share.	14 Jun 2023	3,592	0 (0%)	0%	65.0	233,516	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 64.37 per share.	14 Jun 2023	44,035	3,592 (0%)	0%	64.4	2,834,533	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 63.35 per share.	14 Jun 2023	34,227	47,627 (0%)	0%	63.3	2,168,280	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.73 per share.	14 Jun 2023	4,538	81,854 (0%)	0%	56.7	257,441	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.89 per share.	14 Jun 2023	11,762	77,316 (0%)	0%	36.9	433,900	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.94 per share.	14 Jun 2023	25,082	65,554 (0%)	0%	23.9	600,463	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.63 per share.	14 Jun 2023	40,472	40,472 (0%)	0%	53.6	2,170,513	Common Stock
Robert L. Van Nostrand	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.05 per share.	17 Apr 2023	10,000	19,345 (0%)	0%	13.1	130,500	Common Stock
Robert L. Van Nostrand	Director	Sale of securities on an exchange or to another person at price $ 63.00 per share.	17 Apr 2023	10,000	9,345 (0%)	0%	63	630,000	Common Stock
Robert L. Van Nostrand	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Apr 2023	10,000	0	-		-	Stock Option (right to buy)
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 54.15 per share.	31 Mar 2023	95	9,345 (0%)	0%	54.1	5,144	Common Stock
Rory B. Riggs	Director	Grant, award, or other acquisition of securities at price $ 54.15 per share.	31 Mar 2023	313	78,360 (0%)	0%	54.2	16,949	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 54.86 per share.	28 Mar 2023	5,421	55,522 (0%)	0%	54.9	297,396	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 54.01 per share.	28 Mar 2023	10,183	45,339 (0%)	0%	54.0	549,984	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 44.29 per share.	10 Mar 2023	346	23,104 (0%)	0%	44.3	15,324	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Mar 2023	7,344	30,448 (0%)	0%		-	Common Stock
Suresh K. Durgam	EVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Mar 2023	7,344	14,690	-		-	Restricted Stock Units
Suresh K. Durgam	EVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 45.08 per share.	10 Mar 2023	6,998	23,450 (0%)	0%	45.1	315,470	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 42.52 per share.	09 Mar 2023	2,500	0 (0%)	0%	42.5	106,300	Common Stock
Michael I. Halstead	EVP and General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	16,708	16,708 (0%)	0%		0	Common Stock
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Mar 2023	7,344	14,690	-		-	Restricted Stock Units
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 44.15 per share.	09 Mar 2023	476	0 (0%)	0%	44.1	21,015	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 44.99 per share.	09 Mar 2023	6,868	476 (0%)	0%	45.0	308,991	Common Stock
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Mar 2023	7,344	7,344 (0%)	0%		-	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 43.20 per share.	09 Mar 2023	14,208	2,500 (0%)	0%	43.2	613,786	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.26 per share.	09 Mar 2023	20,000	1,150,309 (1%)	0%	3.3	65,200	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	41,770	1,172,079 (1%)	0%		0	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 43.28 per share.	09 Mar 2023	34,965	1,137,114 (1%)	0%	43.3	1,513,285	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 42.51 per share.	09 Mar 2023	6,805	1,130,309 (1%)	0%	42.5	289,281	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Mar 2023	20,565	1,150,874 (1%)	0%		-	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 45.06 per share.	09 Mar 2023	19,153	1,131,721 (1%)	0%	45.1	863,034	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 44.08 per share.	09 Mar 2023	1,412	1,130,309 (1%)	0%	44.1	62,241	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Mar 2023	20,565	41,131	-		-	Restricted Stock Units
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Mar 2023	20,000	0	-		-	Stock Option (right to buy)
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Mar 2023	5,582	11,164	-		-	Restricted Stock Units
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 44.14 per share.	09 Mar 2023	258	0 (0%)	0%	44.1	11,388	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 44.97 per share.	09 Mar 2023	5,324	258 (0%)	0%	45.0	239,420	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Mar 2023	5,582	5,582 (0%)	0%		-	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 42.52 per share.	09 Mar 2023	2,700	0 (0%)	0%	42.5	114,804	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	15,663	15,663 (0%)	0%		0	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 43.17 per share.	09 Mar 2023	12,963	2,700 (0%)	0%	43.2	559,613	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 43.50 per share.	09 Mar 2023	6,750	59,157 (0%)	0%	43.5	293,625	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Mar 2023	7,344	14,690	-		-	Restricted Stock Units
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 44.05 per share.	09 Mar 2023	423	60,943 (0%)	0%	44.0	18,633	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 45.10 per share.	09 Mar 2023	3,335	61,366 (0%)	0%	45.1	150,409	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Mar 2023	7,344	64,701 (0%)	0%		-	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 42.74 per share.	09 Mar 2023	1,800	57,357 (0%)	0%	42.7	76,932	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	16,708	65,907 (0%)	0%		0	Common Stock
Michael I. Halstead	EVP and General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Mar 2023	39,398	39,398	-		-	Restricted Stock Units
Sharon Mates	Director, Chairman, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Mar 2023	122,137	122,137	-		-	Restricted Stock Units
Lawrence J. Hineline	SVP of Finance CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Mar 2023	39,398	39,398	-		-	Restricted Stock Units
Mark Neumann	EVP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Mar 2023	39,398	39,398	-		-	Restricted Stock Units
Suresh K. Durgam	EVP, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Mar 2023	39,398	39,398	-		-	Restricted Stock Units
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 50.01 per share.	01 Mar 2023	7,241	49,199 (0%)	0%	50.0	362,122	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 47.03 per share.	23 Feb 2023	7,906	0 (0%)	0%	47.0	371,819	Common Stock
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2023	7,906	7,907	-		-	Restricted Stock Units
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2023	7,906	7,906 (0%)	0%		-	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2023	22,590	1,122,899 (1%)	0%		-	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.26 per share.	23 Feb 2023	30,000	1,130,309 (1%)	0%	3.3	97,800	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 47.03 per share.	23 Feb 2023	22,590	1,100,309 (1%)	0%	47.0	1,062,408	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2023	30,000	20,000	-		-	Stock Option (right to buy)
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2023	22,590	22,590	-		-	Restricted Stock Units
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2023	7,455	7,455 (0%)	0%		-	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 47.03 per share.	23 Feb 2023	7,455	0 (0%)	0%	47.0	350,609	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2023	7,455	7,455	-		-	Restricted Stock Units
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2023	7,906	60,486 (0%)	0%		-	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2023	7,906	7,907	-		-	Restricted Stock Units
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 47.12 per share.	23 Feb 2023	4,046	56,440 (0%)	0%	47.1	190,648	Common Stock
Suresh K. Durgam	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2023	7,906	7,907	-		-	Restricted Stock Units
Suresh K. Durgam	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2023	7,906	31,010 (0%)	0%		-	Common Stock
Suresh K. Durgam	SVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 47.14 per share.	23 Feb 2023	7,906	23,104 (0%)	0%	47.1	372,689	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 49.60 per share.	18 Feb 2023	100	0 (0%)	0%	49.6	4,960	Common Stock
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2023	11,139	11,139 (0%)	0%		-	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 46.56 per share.	18 Feb 2023	9,296	1,843 (0%)	0%	46.6	432,822	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 47.23 per share.	18 Feb 2023	643	1,200 (0%)	0%	47.2	30,369	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 48.68 per share.	18 Feb 2023	1,100	100 (0%)	0%	48.7	53,548	Common Stock
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2023	11,139	0	-		-	Restricted Stock Units
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 47.35 per share.	18 Feb 2023	2,200	1,103,062 (1%)	0%	47.4	104,170	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2023	27,848	0	-		-	Restricted Stock Units
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2023	27,848	1,128,157 (1%)	0%		-	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 48.70 per share.	18 Feb 2023	2,502	1,100,560 (1%)	0%	48.7	121,847	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 49.60 per share.	18 Feb 2023	251	1,100,309 (1%)	0%	49.6	12,450	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 46.54 per share.	18 Feb 2023	22,895	1,105,262 (1%)	0%	46.5	1,065,533	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 50.59 per share.	18 Feb 2023	1,689	0 (0%)	0%	50.6	85,447	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2023	10,443	0	-		-	Restricted Stock Units
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.73 per share.	18 Feb 2023	53,968	53,968 (0%)	0%	12.7	687,013	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2023	53,968	0	-		-	Stock Option (right to buy)
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 49.60 per share.	18 Feb 2023	94	0 (0%)	0%	49.6	4,662	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 48.72 per share.	18 Feb 2023	900	94 (0%)	0%	48.7	43,848	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 47.32 per share.	18 Feb 2023	800	994 (0%)	0%	47.3	37,856	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 46.54 per share.	18 Feb 2023	8,649	1,794 (0%)	0%	46.5	402,524	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2023	10,443	10,443 (0%)	0%		-	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 49.81 per share.	18 Feb 2023	52,279	1,689 (0%)	0%	49.8	2,604,017	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 46.61 per share.	18 Feb 2023	3,140	53,338 (0%)	0%	46.6	146,355	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 47.32 per share.	18 Feb 2023	123	53,215 (0%)	0%	47.3	5,820	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 48.93 per share.	18 Feb 2023	635	52,580 (0%)	0%	48.9	31,071	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2023	11,139	0	-		-	Restricted Stock Units
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2023	11,139	56,478 (0%)	0%		-	Common Stock
Suresh K. Durgam	SVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 48.63 per share.	18 Feb 2023	806	23,179 (0%)	0%	48.6	39,196	Common Stock
Suresh K. Durgam	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2023	8,354	0	-		-	Restricted Stock Units
Suresh K. Durgam	SVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 49.60 per share.	18 Feb 2023	75	23,104 (0%)	0%	49.6	3,720	Common Stock
Suresh K. Durgam	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2023	8,354	31,458 (0%)	0%		-	Common Stock
Suresh K. Durgam	SVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 46.55 per share.	18 Feb 2023	6,673	24,785 (0%)	0%	46.5	310,628	Common Stock
Suresh K. Durgam	SVP, Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 47.20 per share.	18 Feb 2023	800	23,985 (0%)	0%	47.2	37,760	Common Stock
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 52.92 per share.	30 Dec 2022	97	9,250 (0%)	0%	52.9	5,133	Common Stock
Rory B. Riggs	Director	Grant, award, or other acquisition of securities at price $ 52.92 per share.	30 Dec 2022	321	78,047 (0%)	0%	52.9	16,987	Common Stock
Joel S. Marcus	Director	Sale of securities on an exchange or to another person at price $ 50.82 per share.	19 Dec 2022	5,000	29,233 (0%)	0%	50.8	254,100	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 55.00 per share.	13 Dec 2022	33,083	1,100,309 (1%)	0%	55	1,819,565	Common Stock
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Dec 2022	50,000	15,164	-		-	Stock Option (right to buy)
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 53.94 per share.	01 Dec 2022	27,204	22,796 (0%)	0%	53.9	1,467,384	Common Stock
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.47 per share.	01 Dec 2022	50,000	50,000 (0%)	0%	15.5	773,500	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 53.48 per share.	01 Dec 2022	22,796	0 (0%)	0%	53.5	1,219,130	Common Stock
Joel S. Marcus	Director	Sale of securities on an exchange or to another person at price $ 52.11 per share.	07 Nov 2022	5,000	34,233 (0%)	0%	52.1	260,559	Common Stock
Joel S. Marcus	Director	Sale of securities on an exchange or to another person at price $ 52.49 per share.	07 Nov 2022	5,000	39,233 (0%)	0%	52.5	262,465	Common Stock
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 46.53 per share.	30 Sep 2022	110	9,153 (0%)	0%	46.5	5,118	Common Stock
Rory B. Riggs	Director	Grant, award, or other acquisition of securities at price $ 46.53 per share.	30 Sep 2022	365	77,726 (0%)	0%	46.5	16,983	Common Stock
Joel S. Marcus	Director	Sale of securities on an exchange or to another person at price $ 59.22 per share.	11 Aug 2022	10,000	44,233 (0%)	0%	59.2	592,200	Common Stock
Robert L. Van Nostrand	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Aug 2022	20,000	0	-		-	Stock Option (right to buy)
Robert L. Van Nostrand	Director	Sale of securities on an exchange or to another person at price $ 56.80 per share.	11 Aug 2022	1,500	9,043 (0%)	0%	56.8	85,200	Common Stock
Robert L. Van Nostrand	Director	Sale of securities on an exchange or to another person at price $ 57.15 per share.	11 Aug 2022	28,500	10,543 (0%)	0%	57.2	1,628,775	Common Stock
Robert L. Van Nostrand	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.05 per share.	11 Aug 2022	10,000	39,043 (0%)	0%	13.1	130,500	Common Stock
Robert L. Van Nostrand	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.45 per share.	11 Aug 2022	20,000	29,043 (0%)	0%	12.5	249,000	Common Stock
Robert L. Van Nostrand	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Aug 2022	10,000	10,000	-		-	Stock Option (right to buy)
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 57.08 per share.	30 Jun 2022	108	9,043 (0%)	0%	57.1	6,165	Common Stock
Rory B. Riggs	Director	Grant, award, or other acquisition of securities at price $ 57.08 per share.	30 Jun 2022	289	77,361 (0%)	0%	57.1	16,496	Common Stock
Joel S. Marcus	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2022	16,757	16,757	-		-	Stock Option (right to buy)
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2022	16,757	16,757	-		-	Stock Option (right to buy)
Rory B. Riggs	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2022	16,757	16,757	-		-	Stock Option (right to buy)
Michael Rawlins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2022	16,757	16,757	-		-	Stock Option (right to buy)
Eduardo Rene Salas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2022	16,757	16,757	-		-	Stock Option (right to buy)
Eduardo Rene Salas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Apr 2022	20,000	20,000	-		-	Stock Option (right to buy)
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 63.55 per share.	08 Apr 2022	17,476	114,211 (0%)	0%	63.6	1,110,600	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Apr 2022	86,348	0	-		-	Stock Option (right to buy)
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 65.14 per share.	08 Apr 2022	14,885	45,339 (0%)	0%	65.1	969,609	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 64.42 per share.	08 Apr 2022	53,987	60,224 (0%)	0%	64.4	3,477,843	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.73 per share.	08 Apr 2022	86,348	131,687 (0%)	0%	12.7	1,099,210	Common Stock
Robert L. Van Nostrand	Director	Grant, award, or other acquisition of securities at price $ 61.19 per share.	31 Mar 2022	126	8,935 (0%)	0%	61.2	7,710	Common Stock
Rory B. Riggs	Director	Grant, award, or other acquisition of securities at price $ 61.19 per share.	31 Mar 2022	257	77,072 (0%)	0%	61.2	15,726	Common Stock
Michael I. Halstead	EVP and General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	22,034	22,034	-		-	Restricted Stock Units
Michael I. Halstead	EVP and General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	17,916	17,916	-		-	Stock Option (right to buy)
Sharon Mates	Director, Chairman, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	50,167	50,167	-		-	Stock Option (right to buy)
Sharon Mates	Director, Chairman, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	61,696	61,696	-		-	Restricted Stock Units
Lawrence J. Hineline	SVP of Finance CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	16,746	16,746	-		-	Restricted Stock Units
Lawrence J. Hineline	SVP of Finance CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	13,616	13,616	-		-	Stock Option (right to buy)
Mark Neumann	EVP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	17,916	17,916	-		-	Stock Option (right to buy)
Mark Neumann	EVP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	22,034	22,034	-		-	Restricted Stock Units
Suresh K. Durgam	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	17,916	17,916	-		-	Stock Option (right to buy)
Suresh K. Durgam	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	22,034	22,034	-		-	Restricted Stock Units
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Mar 2022	38,925	0	-		-	Stock Option (right to buy)
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.84 per share.	09 Mar 2022	38,925	1,133,392 (1%)	0%	2.8	110,547	Common Stock
Joel S. Marcus	Director	Sale of securities on an exchange or to another person at price $ 52.89 per share.	07 Mar 2022	10,000	28,980 (0%)	0%	52.9	528,900	Common Stock
Joel S. Marcus	Director	Sale of securities on an exchange or to another person at price $ 54.52 per share.	07 Mar 2022	5,000	43,980 (0%)	0%	54.5	272,600	Common Stock
Joel S. Marcus	Director	Sale of securities on an exchange or to another person at price $ 52.25 per share.	07 Mar 2022	5,000	38,980 (0%)	0%	52.3	261,250	Common Stock
Suresh K. Durgam	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 55.52 per share.	02 Mar 2022	3,860	23,104 (0%)	0%	55.5	214,307	Common Stock
Suresh K. Durgam	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 56.98 per share.	02 Mar 2022	4,177	26,964 (0%)	0%	57.0	238,005	Common Stock
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2022	11,139	11,139	-		-	Restricted Stock Units
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 54.98 per share.	18 Feb 2022	4,550	0 (0%)	0%	55.0	250,159	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 55.69 per share.	18 Feb 2022	6,589	4,550 (0%)	0%	55.7	366,941	Common Stock
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2022	11,139	11,139 (0%)	0%		-	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 55.73 per share.	18 Feb 2022	15,180	1,107,134 (1%)	0%	55.7	845,981	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2022	27,847	27,848	-		-	Restricted Stock Units
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2022	27,847	1,122,314 (1%)	0%		-	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 54.98 per share.	18 Feb 2022	12,667	1,094,467 (1%)	0%	55.0	696,432	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 55.72 per share.	18 Feb 2022	5,816	4,627 (0%)	0%	55.7	324,068	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2022	10,443	10,443	-		-	Restricted Stock Units
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 54.99 per share.	18 Feb 2022	4,627	0 (0%)	0%	55.0	254,439	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2022	10,443	10,443 (0%)	0%		-	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2022	11,139	11,139	-		-	Restricted Stock Units
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 54.84 per share.	18 Feb 2022	4,607	45,339 (0%)	0%	54.8	252,648	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 55.60 per share.	18 Feb 2022	6,532	49,946 (0%)	0%	55.6	363,179	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2022	11,139	56,478 (0%)	0%		-	Common Stock
Suresh K. Durgam	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2022	8,354	31,458 (0%)	0%		-	Common Stock
Suresh K. Durgam	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 55.53 per share.	18 Feb 2022	2,820	28,638 (0%)	0%	55.5	156,595	Common Stock
Suresh K. Durgam	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 54.80 per share.	18 Feb 2022	1,357	27,281 (0%)	0%	54.8	74,364	Common Stock
Suresh K. Durgam	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Feb 2022	8,354	8,354	-		-	Restricted Stock Units
Suresh K. Durgam	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 42.03 per share.	18 Jan 2022	6,223	23,104 (0%)	0%	42.0	261,553	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 40.12 per share.	08 Jan 2022	4,380	0 (0%)	0%	40.1	175,726	Common Stock
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jan 2022	19,639	19,639 (0%)	0%		-	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 41.74 per share.	08 Jan 2022	2,504	17,135 (0%)	0%	41.7	104,517	Common Stock
Michael I. Halstead	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 40.81 per share.	08 Jan 2022	12,755	4,380 (0%)	0%	40.8	520,532	Common Stock
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jan 2022	19,639	0	-		-	Restricted Stock Units
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 41.72 per share.	08 Jan 2022	5,804	1,130,559 (1%)	0%	41.7	242,143	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jan 2022	41,896	0	-		-	Restricted Stock Units
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 40.10 per share.	08 Jan 2022	8,954	1,094,467 (1%)	0%	40.1	359,055	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 40.80 per share.	08 Jan 2022	27,138	1,103,421 (1%)	0%	40.8	1,107,230	Common Stock
Sharon Mates	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jan 2022	41,896	1,136,363 (1%)	0%		-	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jan 2022	19,639	0	-		-	Restricted Stock Units
Lawrence J. Hineline	SVP of Finance CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jan 2022	19,639	19,639 (0%)	0%		-	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 41.61 per share.	08 Jan 2022	3,105	16,534 (0%)	0%	41.6	129,199	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 40.77 per share.	08 Jan 2022	12,434	4,100 (0%)	0%	40.8	506,934	Common Stock
Lawrence J. Hineline	SVP of Finance CFO	Sale of securities on an exchange or to another person at price $ 40.07 per share.	08 Jan 2022	4,100	0 (0%)	0%	40.1	164,287	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 41.74 per share.	08 Jan 2022	2,761	63,526 (0%)	0%	41.7	115,244	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jan 2022	20,948	0	-		-	Restricted Stock Units
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 40.09 per share.	08 Jan 2022	4,252	45,339 (0%)	0%	40.1	170,463	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 40.80 per share.	08 Jan 2022	13,935	49,591 (0%)	0%	40.8	568,548	Common Stock
Mark Neumann	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jan 2022	20,948	66,287 (0%)	0%		-	Common Stock
Suresh K. Durgam	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jan 2022	13,093	36,197 (0%)	0%		-	Common Stock
Suresh K. Durgam	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jan 2022	13,093	0	-		-	Restricted Stock Units
Suresh K. Durgam	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 39.83 per share.	08 Jan 2022	500	29,327 (0%)	0%	39.8	19,915	Common Stock
Suresh K. Durgam	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 40.63 per share.	08 Jan 2022	4,850	29,827 (0%)	0%	40.6	197,056	Common Stock
Suresh K. Durgam	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 41.48 per share.	08 Jan 2022	1,520	34,677 (0%)	0%	41.5	63,050	Common Stock
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Dec 2021	63,717	0	-		-	Stock Option (right to buy)
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Dec 2021	88,146	0	-		-	Stock Option (right to buy)
Michael I. Halstead	EVP and General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Dec 2021	25,000	0	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

New 52W High today

Insider Trading disclosures for Intra-Cellular Therapies Inc

The latest disclosure was made by Michael I. Halstead in Intra-Cellular Therapies Inc where a trade of 7,345 Common Stock done was reported to US exchanges on March 6, 2025.

Screeners based on Insider Trading and SAST parameters